Tuberculosis: detection of mycobacteria and diagnostic methods

Detection of Mycobacterium tuberculosis is not a single test, but an entire diagnostic system, the purpose of which is to confirm the presence of the pathogen, determine the form of the disease, and identify drug resistance as early as possible. Modern practice is no longer limited to searching for acid-fast bacteria under a microscope. Rapid molecular methods are now prioritized, and microscopy, culture, resistance testing, and clinical evaluation are considered part of a single approach. [1]

The main reason for this restructuring is simple: bacteriological confirmation of tuberculosis is needed not only to "settle" a diagnosis. It is also essential for choosing the right treatment, because without detecting mycobacteria, it is impossible to fully assess resistance to anti-tuberculosis drugs. The World Health Organization explicitly emphasizes that bacterial confirmation is especially important for drug resistance testing. [2]

It's important to remember that tuberculosis isn't limited to the lungs. Some patients also have lymph node, pleural, meningeal, bone, urinary tract, and other organ involvement. In people living with the human immunodeficiency virus and in children, the clinical picture is often atypical, bacterial excretion may be scanty, and sputum specimens are difficult to obtain. Therefore, modern diagnostics must be flexible and tailored to the specific clinical scenario. [3]

From a practical standpoint, the physician answers four questions: Does the patient have signs of active tuberculosis? Has the pathogen itself been detected? Are there signs of drug resistance? And is the patient simply infected without active disease? An error at even one of these stages changes treatment tactics and epidemic control decisions. [4]

That's why the old "take a fluorography, find changes, look at the smear" approach is no longer sufficient. Modern materials on this topic should explain not only the methods but also their place in the algorithm: when to take which sample, which test is needed first, how to confirm the result, and why a negative result doesn't always rule out tuberculosis. [5]

Table 1. What exactly does each level of diagnostics provide?

Assessment level	What does it show?	What it doesn't give
Clinical assessment and complaints	Allows one to suspect the disease	Does not confirm the presence of mycobacteria
Chest X-ray	Helps to see changes compatible with tuberculosis	Does not definitively prove tuberculosis
Smear microscopy	Quickly detects the presence of acid-fast bacteria	Does not distinguish tuberculosis from some other mycobacteria, poor sensitivity
Rapid molecular test	Rapidly detects Mycobacterium tuberculosis complex and often rifampicin resistance	Does not replace sowing and a full search for resistance
Sowing	Remains a laboratory standard for confirmation	It takes time
Drug resistance research	Helps to choose a treatment regimen	It is impossible without high-quality bacteriological material

Sources for the table: [6]

What does the detection of mycobacteria mean and why is bacteriological confirmation so important?

When a report or form mentions the detection of Mycobacterium tuberculosis, it typically refers to the detection of Mycobacterium tuberculosis complex in a clinical specimen. This may include sputum, aspirate, cerebrospinal fluid, urine, lymph node material, and other samples, depending on the location of the infection. The mere detection of the pathogen elevates the diagnosis from a presumptive to a bacteriologically confirmed case. [7]

This is crucial because bacteriologically confirmed tuberculosis not only allows for earlier treatment but also allows for the assessment of drug resistance. The World Health Organization emphasizes that bacteriological confirmation is essential for testing for resistance to anti-tuberculosis drugs. Without it, a physician risks prescribing a regimen that will not work in the presence of resistance. [8]

However, clinically diagnosed tuberculosis also exists. The World Health Organization notes that some patients are diagnosed without bacteriological confirmation, i.e., clinically. This does not mean an error. It does mean that in some situations, the sensitivity of the methods is insufficient, especially in cases of extrapulmonary disease, low bacterial excretion, or in children. Therefore, a negative laboratory test does not always mean the absence of the disease. [9]

Microbiological detection is also important from an epidemiological perspective. The higher the bacterial load, the higher the likelihood of infectiousness, especially in pulmonary infections. Microscopy of a smear for acid-fast bacteria still helps quickly assess the likelihood of infectiousness, although it is not the best initial test for primary diagnosis. [10]

Finally, detection of mycobacteria is the starting point for further laboratory testing. After a positive result, it is important for the physician to determine whether the pathogen is susceptible to rifampicin, isoniazid, fluoroquinolones, and other key drugs. Modern recommendations are increasingly shifting toward earlier molecular resistance testing to avoid wasting weeks waiting. [11]

Table 2. What does positive detection mean in different methods?

Method	What does a positive result mean?	Practical conclusion
Smear microscopy	Acid-fast bacteria discovered	The patient is likely infectious, but further testing for tuberculosis complex is needed.
Rapid molecular test	Mycobacterium tuberculosis complex was detected	Tuberculosis can be quickly confirmed and rifampin can often be assessed immediately.
Sowing	Mycobacterium tuberculosis complex was grown	Laboratory confirmation of diagnosis
Molecular resistance test	Mutations associated with resistance have been found	It is necessary to adjust the treatment tactics

Sources for the table: [12]

When should I look for mycobacteria and what samples are taken?

Mycobacteria should be tested in every person with symptoms compatible with tuberculosis, as well as in people who test positive for tuberculosis infection if there remains a possibility of active disease. The US Centers for Disease Control and Prevention emphasizes that anyone with symptoms of tuberculosis or a positive test for the infection should undergo a full medical evaluation for active disease. [13]

If pulmonary tuberculosis is suspected, sputum remains the primary specimen. According to the US Centers for Disease Control and Prevention, in patients with suspected pulmonary tuberculosis, it is advisable to test at least three consecutive sputum samples, collected at intervals of 8-24 hours, with at least one in the morning. This increases the likelihood of detecting mycobacteria, especially if bacterial excretion is low. [14]

If sputum cannot be obtained, other methods are used: induced sputum, bronchoscopic specimens, gastric aspirate, and, in children, also stool and nasopharyngeal aspirate. The World Health Organization recommends using modern rapid molecular assays on sputum, nasopharyngeal aspirate, gastric aspirate, or stool as an initial test in children with signs of pulmonary tuberculosis. [15]

For extrapulmonary tuberculosis, the sample is selected based on location: cerebrospinal fluid (CSF) for suspected tuberculous meningitis, lymph node material for lymphadenitis, pleural, pericardial, peritoneal, or synovial fluid for the corresponding forms, and urine for suspected urinary tract infection. The World Health Organization (WHO) indicates that rapid molecular assays can be used for a number of non-respiratory samples, and this recommendation is particularly strong for CSF. [16]

For people living with human immunodeficiency virus and for those with severe illness, sample routing may be broader. For some patients with suspected disseminated tuberculosis, the World Health Organization allows the use of a molecular test on blood and also recommends, in appropriate cases, a urine lipoarabinomannan test as an additional rapid diagnostic aid. [17]

Table 3. Which samples are used for different forms of the disease

Estimated form	Preferred samples
Pulmonary tuberculosis in adults	Sputum, induced sputum, bronchoscopic material
Pulmonary tuberculosis in children	Sputum, nasopharyngeal aspirate, gastric aspirate, feces
Tuberculosis of the meninges	Liquor
Tuberculosis of the lymph nodes	Puncture or biopsy material
Pleural, pericardial, peritoneal, synovial tuberculosis	Appropriate liquid or tissue
Disseminated tuberculosis in people with human immunodeficiency virus	Respiratory samples, in some cases blood, urine for lipoarabinomannan

Sources for the table: [18]

The main methods of detection are microscopy, rapid molecular tests and culture.

Smear microscopy remains the oldest and most accessible method, but its capabilities are limited. During microscopy, the sample is stained and examined under a microscope for the presence of acid-fast bacteria. The Centers for Disease Control and Prevention (CDC) notes that the results of this test are typically available within 24 hours, and the degree of positivity of the smear helps determine the patient's infectiousness. [19]

The problem is that a negative smear does not rule out tuberculosis, and a positive smear does not always prove tuberculosis complex, as other mycobacteria can also be acid-fast. Furthermore, microscopy has low sensitivity in people living with the human immunodeficiency virus, in children, and when the sample contains a small number of bacteria. This is why the World Health Organization recommends replacing microscopy as the initial test with rapid molecular methods. [20]

Rapid molecular assays are now considered the basis for initial diagnostics. They allow for the detection of the genetic material of Mycobacterium tuberculosis complex within hours and, depending on the system, immediate identification of mutations associated with rifampicin resistance. The World Health Organization recommends such tests as initial testing for both pulmonary and most extrapulmonary forms of the disease in adults, children, and people living with the human immunodeficiency virus. [21]

However, a rapid molecular test does not replace other methods. The US Centers for Disease Control and Prevention emphasizes that molecular testing assists in isolation and treatment decisions, but does not replace microscopy, culture, phenotypic drug susceptibility testing, and other recommended mycobacteriological tests. This is a very important practical point: a modern test speeds up the initial response, but does not cover the entire route. [22]

Culture remains the laboratory standard for confirmation. According to the US Centers for Disease Control and Prevention, culture is required for all specimens, regardless of whether the smear is positive or negative. A positive culture confirms the diagnosis, while a negative culture does not always rule out the disease, as some patients are still diagnosed clinically. It is from the culture that full drug susceptibility testing and additional epidemiological studies are often performed. [23]

Table 4. Strengths and weaknesses of the main methods

Method	Advantages	Restrictions
Smear microscopy	Fast, cheap, helps assess infectiousness	Low sensitivity, does not distinguish between the full spectrum of mycobacteria and resistance
Rapid molecular test	Quickly identifies tuberculosis complex, often immediately showing rifampicin	Does not replace sowing and full resistance testing
Sowing	Laboratory confirmation standard, needed for further study of sustainability	Slow result
Phenotypic study of resistance	Shows real sensitivity to drugs	Requires culture and time
Advanced molecular resistance methods	Accelerate the search for resistance to multiple drugs	Laboratory capacity and correct interpretation are needed

Sources for the table: [24]

Drug resistance: why it needs to be detected as early as possible

Modern tuberculosis diagnostics are no longer limited to determining whether the pathogen is present. Equally important is the question of whether it is resistant to key drugs. The World Health Organization emphasizes that all patients with bacteriologically confirmed tuberculosis should be tested for rifampicin resistance, as this is essential for selecting the appropriate treatment regimen. [25]

Rapid molecular assays are particularly valuable because they allow for the early detection of rifampicin resistance. This is critical for initial treatment: clinicians can more quickly determine whether a drug-sensitive process is present or whether a drug-resistant variant needs urgent attention. The US Centers for Disease Control and Prevention recommends rapid molecular resistance testing immediately in the presence of risk factors for resistant tuberculosis, a positive smear, or a positive molecular test. [26]

After an initial response, more extensive resistance testing is often required. The World Health Organization (WHO) recommends that several classes of tests, including linear probe assays, highly sophisticated molecular methods, and targeted sequencing, be used to further detect resistance to isoniazid, fluoroquinolones, and other drugs. This level of testing is not needed for everyone as a first step, but rather for those with a risk or signs of resistance. [27]

The importance of sequencing is growing particularly rapidly because it allows a single study to search for mutations associated with resistance to multiple drugs at once. In 2024, the World Health Organization included this class of technologies in its recommendations for the subsequent determination of resistance to a range of first- and second-line drugs. This is an important update that was not included in older articles. [28]

Despite advances in molecular methods, phenotypic susceptibility testing remains important. The US Centers for Disease Control and Prevention emphasizes that drug selection should rely on both molecular and growth-based methods when available. This is especially important in complex cases where the mutational profile is ambiguous or susceptibility to multiple drugs must be confirmed. [29]

Table 5. How drug resistance is searched for today

Stage	What are they looking for?	What are they looking for?
Starting fast stage	First of all, resistance to rifampicin	Rapid molecular test
Subsequent extended stage	Resistance to isoniazid and a number of second-line drugs	Specialized molecular tests
Clarification stage	Confirmation of sensitivity and stability	Phenotypic study on culture
Advanced stage	Simultaneous search for mutations to several drugs	Targeted sequencing

Sources for the table: [30]

Special situations: children, human immunodeficiency virus, and extrapulmonary tuberculosis

Diagnosing tuberculosis in children is particularly challenging because young patients often have difficulty coughing up mucus, and their bacterial load is often lower than that of adults. This is why the World Health Organization recommends using rapid molecular assays on several types of specimens in children, including gastric aspirate and stool. This is a very important change for modern pediatric practice. [31]

In addition, integrated decision-making algorithms can be used in children, which combine symptoms, radiography, bacteriological tests, and available pediatric specimens. The World Health Organization emphasizes that bacteriological confirmation should be sought whenever possible, but in childhood tuberculosis, the physician is often forced to make a decision based on a combination of features. [32]

People living with the human immunodeficiency virus (HIV) present a different problem. They are more likely to have extrathoracic and disseminated forms, the radiographic appearance may be less typical, and sputum specimens may be more difficult to obtain. The World Health Organization recommends using a rapid molecular test as an initial method in such patients, and, if necessary, expanding the diagnostic workup to include a parallel urine test for lipoarabinomannan. [33]

In extrapulmonary tuberculosis, sample selection becomes critical. For cerebrospinal fluid (CSF), lymph node specimens, and a number of serous fluids, rapid molecular methods are recommended as an essential part of the algorithm. A particularly strong recommendation is given for CSF, as delay in the diagnosis of meningeal lesions is extremely dangerous. [34]

Finally, in 2025, the World Health Organization separately updated its approaches to the simultaneous testing of multiple specimen types. For children without human immunodeficiency virus (HIV) or with unknown status, parallel testing of respiratory and stool specimens is recommended, while for children and adults with human immunodeficiency virus (HIV), urine testing for lipoarabinomannan may be added to this regimen. This increases the likelihood of detecting the disease in complex patients. [35]

Table 6. Important things to remember in special groups

Patient group	The main diagnostic problem	Modern accent
Children	It is difficult to obtain sputum, often there are few bacteria	Use gastric aspirate, stool, nasopharyngeal aspirate, integrated algorithms
People with human immunodeficiency virus	Atypical and disseminated picture, often extrapulmonary forms	Rapid molecular tests as initial tests, in some cases urine for lipoarabinomannan
Extrapulmonary tuberculosis	The right choice of material is needed	Examine cerebrospinal fluid, nodes, serous fluids and other materials by localization
Suspected of a persistent process	Need to quickly understand the sustainability profile	Early molecular search for resistance and further refinement

Sources for the table: [36]

Infection Tests and Disease Tests: What Not to Confuse

One of the most common mistakes is to assume that a positive tuberculin skin test or a positive blood test for the immune response already proves active tuberculosis. In fact, these methods show that the immune system has encountered Mycobacterium tuberculosis, meaning they help detect infection. However, they do not distinguish between latent infection and active disease. [37]

The U.S. Centers for Disease Control and Prevention emphasizes that latent tuberculosis infection is diagnosed when a test for the infection is positive, but a medical evaluation does not confirm active disease. This means that even after a positive test for the infection, the patient still requires an examination, chest X-ray, and, if symptoms are present, bacteriological testing. [38]

Equally important is the reverse: a negative immunological test does not always rule out active tuberculosis. In a symptomatic patient, a physician should not wait for the results of such a test before initiating other diagnostic procedures. This is especially true in cases of immunodeficiency and severe illness, when the immune response may be weakened. [39]

A chest X-ray can help differentiate latent infection from a probable pulmonary process, but it alone does not provide a definitive diagnosis. The US Centers for Disease Control and Prevention (CDC) notes that changes on the X-ray may suggest tuberculosis, but cannot be used as a definitive diagnosis. However, a normal X-ray in an asymptomatic person with a positive test for the infection usually helps rule out the pulmonary form, although there are exceptions. [40]

The practical conclusion is simple. Infection tests are needed to identify those infected and prevent future illness. Mycobacterium detection tests are needed to confirm active disease and determine resistance. Confusing these two levels creates most of the errors in old and simplified articles. [41]

Table 7. How does infection differ from active tuberculosis?

Question	Latent infection	Active tuberculosis
Are there any symptoms?	Usually no	Often there is, but not always
What do immunological tests show?	May be positive	They can also be positive, but do not confirm the disease.
Is an X-ray necessary?	Yes, to exclude the active process	Yes, as part of the diagnostics
Is it necessary to search for mycobacteria?	Usually no, unless active disease is excluded	Yes, definitely if possible.
Is a resistance test necessary?	No	Yes, if the pathogen is detected

Sources for the table: [42]

How to interpret the results and when treatment should not be delayed

Tuberculosis results are almost never assessed in isolation from clinical examination. A positive molecular test on sputum, accompanied by symptoms and imaging changes, is a strong argument for active pulmonary tuberculosis. A positive smear without further confirmation requires clarification, as acid-fast bacteria may be present in species other than mycobacteria tuberculosis complex. A negative smear, despite a high clinical probability of the disease, does not resolve the issue. [43]

A positive culture remains the most convincing laboratory confirmation. However, a negative culture does not always mean the absence of disease. The US Centers for Disease Control and Prevention explicitly states that some patients with negative cultures are still diagnosed with tuberculosis based on their clinical presentation. This is especially important to remember in cases of childhood, extrapulmonary, and immunodeficiency tuberculosis. [44]

A chest X-ray is helpful, but does not definitively confirm the diagnosis. Changes may resemble other lung diseases, and sometimes, with human immunodeficiency virus and compromised immune status, the picture is less typical. Therefore, a final assessment is always based on at least three layers: clinical examination, imaging, and bacteriology. [45]

A very important modern rule is that treatment should not be unnecessarily delayed pending bacteriological results if clinical suspicion is high. The US Centers for Disease Control and Prevention emphasizes that in cases of suspected tuberculosis, therapy is often initiated immediately after specimen collection, and in severely ill patients, even while specimen collection is ongoing. This is especially important in cases of meningitis, severe disseminated disease, and a high probability of infectious pulmonary tuberculosis. [46]

Ultimately, correct interpretation requires not the question "is the test positive or negative," but rather the question "what is the probability of disease now, and how does this result change the physician's actions?" This is precisely how modern algorithms are structured: a rapid initial test, parallel selection of the correct sample, subsequent confirmation by culture, and the earliest possible detection of resistance. [47]

Table 8. How combinations of results are usually interpreted

Situation	The most likely interpretation
Symptoms, changes in the image, positive rapid molecular test	Active tuberculosis is very likely
Symptoms, smear positive, molecular test pending	There is a high probability of an infectious process; a rapid, clarifying test is needed.
There are symptoms, the smear is negative, but the molecular test is positive	Tuberculosis is possible and requires management as an active process.
There are symptoms, smear and culture are negative, but the clinical picture is typical	Tuberculosis is not completely excluded; the decision is made based on a combination of data
The immunological test is positive, there are no symptoms, the image shows no pathology.	Looks more like a latent infection rather than an active disease.

Sources for the table: [48]

Conclusion

Modern detection of Mycobacterium tuberculosis is a multi-step process, in which rapid molecular methods, rather than microscopy alone, increasingly play a key role. The World Health Organization recommends this transition because it speeds diagnosis and identifies the risk of rifampicin resistance earlier. [49]

Microscopy, culture, and phenotypic susceptibility testing remain essential. Microscopy helps quickly assess infectivity, culture remains the laboratory standard for confirmation, and a complete resistance study is necessary for choosing the right treatment, especially if drug-resistant disease is suspected. [50]

Children, people living with human immunodeficiency virus (HIV), and patients with extrapulmonary tuberculosis require a particularly careful approach. For them, proper sample selection, parallel testing of multiple samples, and more flexible algorithms than for typical adult pulmonary tuberculosis are essential. [51]

The key practical conclusion is this: we must look not only for the disease, but also for the pathogen itself; not only for the pathogen, but also for drug resistance; and not only for the laboratory response, but also for its place in the clinical picture. Only this approach is consistent with the current evidence base and real-world clinical practice. [52]

FAQ

What does "detection of Mycobacterium tuberculosis" mean?

This is the detection of Mycobacterium tuberculosis complex in a clinical specimen, such as sputum, cerebrospinal fluid, urine, or lymph node material. This detection elevates the diagnosis to the level of bacteriological confirmation. [53]

Which method is considered the initial one today?

Current World Health Organization guidelines prioritize rapid molecular assays as the initial test over microscopy in most patients with suspected tuberculosis.[54]

Is one sputum smear enough?

Usually no. If pulmonary tuberculosis is suspected, a series of sputum samples are tested. The US Centers for Disease Control and Prevention recommends at least three consecutive samples, one of which should be taken in the morning, at intervals of 8-24 hours. [55]

Does a negative smear rule out tuberculosis?

No. A negative smear does not rule out the disease, especially in children, people with human immunodeficiency virus, and those with low bacterial excretion. Molecular methods, culture, and clinical evaluation are needed for clarification. [56]

Why do you need a culture if you already have a rapid molecular test?

Because culture remains the laboratory standard for confirmation and is needed for further studies of resistance and a number of epidemiological tasks. A rapid molecular test speeds up the response, but does not completely replace culture. [57]

Can a diagnosis be made using a tuberculin test or a blood test for immune response?

No, these tests help identify infection, but do not confirm active tuberculosis. If the disease is suspected, X-rays and bacteriological methods are needed. [58]

What role models are important in children?

In children, in addition to sputum, gastric aspirate, nasopharyngeal aspirate, and stool are used. The World Health Organization recommends modern rapid molecular methods on these samples as the initial approach in pediatric diagnosis. [59]

When should we look for drug resistance?

As soon as possible after bacteriological confirmation, and it is desirable to assess rifampicin resistance at the initial stage using rapid molecular tests. If there is a risk of resistant tuberculosis, extensive testing is required. [60]

What is especially important for people living with human immunodeficiency virus?

They are more likely to have extrapulmonary and disseminated forms, and conventional microscopy is less effective. Therefore, priority is given to rapid molecular methods, and in some cases, a urine test for lipoarabinomannan is also used. [61]

Is it possible to start treatment before all the tests are ready?

Yes, if clinical suspicion is high and especially if the patient is severely ill. Current guidelines allow for the initiation of therapy immediately after sample collection, without waiting for all bacteriological results. [62]